Selecting an IRT vendor is an important investment for your clinical trial. In this guide, you’ll learn how to reduce workload at the investigator site, increase protocol compliance, and increase patient engagement and retention.
Drug development has never before been so difficult, time consuming and expensive. Accuracy in clinical trials, therefore, is a priority. However, suboptimal adherence is prevalent in ambulatory trials, in which outpatients are responsible for taking the drug according to the protocol-specified dosing regimen. Unfortunately, most methods for measuring medication adherence are inaccurate, which can result in costly phase III failures. This whitepaper focuses on a proven exception—automatic adherence measurement through electronic compilation of drug dosing histories. Electronic measurement enables a better understanding of drug safety and efficacy data, improving the likelihood of a successful trial outcome and more informed development decisions, leading to faster speed to commercialization.
Comprehensive 15-page eyeforpharma briefing featuring interviews with 19 senior clinical trial leaders, best patient centricity practices and executive action points from Eli Lilly, Genzyme, National Breast Cancer Coalition, CTTI, PCORI, UCB, Cancer Treatment Centers of America, Michael J. Fox Foundation and more
This white paper explores how medical imaging systems can improve sites' overall experience in an imaging trial, how processes designed to support sites ultimately benefit all trial participants, and how site staff burdened with fewer manual processes can spend more time with patients, get patients on therapy sooner and deliver results to sponsors faster.
Barnett offers training and recourses for Clinical Research Professionals. Included are several new training programs, all designed with a practical, job-focused purpose and the needs of our learners in mind. New training offerings include In-Person Seminars, Web-Based 30-hour Certification Programs, Web Seminars, and Publications.
Hypromellose (HPMC) capsules were originally formulated with a secondary gelling agent. This agent can delay dissolution in some circumstances and lead to unwanted issues during product development. In this article, we discuss the rationale for developing Capsugel’s Vcaps® Plus capsules without a gelling agent. We also describe how these capsules – now in use at many major pharmaceutical companies to encapsulate their existing over-the-counter [OTC] products and New Chemical Entities [NCEs] – can optimize product performance and improve product stability, as well as reduce development timelines.
If it’s true that two heads are better than one, then three, four or heck, maybe 304 heads working in partnership must be even better, right? Well, it depends. Building partnerships that are both smart and sustainable takes planning, patience and perseverance. In this whitepaper, Merge eClinical’s President Zaher El-Assi shares lessons learned and the core practices his company uses to forge long-term partnerships that produce value for both companies that goes beyond the traditional buy-sell relationship.
Are you a clinical research professional looking for training resources? Barnett's July 2014 - January 2015 Course & Publications Catalog offers a variety of training programs. These programs are designed to maximize learner engagement and include the following: In-Person and Web-Based training courses, custom programs and services, eLearning, and Publications.